Loading...

Solventum Corporation

SOLV•NYSE
Healthcare
Medical - Care Facilities
$69.04
$1.60(2.37%)
U.S. Market opens in 1h 31m

Solventum Corporation (SOLV) Stock Overview

Explore Solventum Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12B
P/E Ratio7.71
EPS (TTM)$8.88
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$59.72
3 Months$71.47
1 Year Target$83.39

SOLV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Solventum Corporation (SOLV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.41, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $83.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 7.71 and a market capitalization of 12B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.39%
5-Day Change
3.34%
1-Month Change
9.18%
3-Month Change
-10.29%
6-Month Change
2.02%
Year-to-Date (YTD) Change
-12.85%
1-Year Change
3.24%
3-Year Change
-13.68%
5-Year Change
-13.68%
All-Time (Max) Change
-13.68%

Contact Information

https://www.solventum.com
651-733-1110
3M Center, Maplewood, MN, 55144

Company Facts

22,000 Employees
IPO DateApr 1, 2024
CountryUS
Actively Trading

Frequently Asked Questions